Presentation ACC 2012

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Presenter: Myeong-Ki Hong

March 25, 2012

REGISTER for free or LOG IN to view this content

A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial

Clinical Pharma

Prevention

CAD Pharma

DES/BRS/DCB

Presentation

ACC 2012

Up Next

Presentation

TAVR with the St. Jude Medical Portico Valve: First-in-Human Experience

Presenter: A.B. Wilson

May 31, 2012

More slides +

Presentation TCT 2012

Prediction of distal embolization during percutaneous coronary intervention for unstable plaques with grayscale and integrated backscatter intravascular ultrasound

Presenter: Daisuke Morisawa

January 03, 2012

Presentation TCT 2012

Optimal Cut-off Value of Coronary Flow Velocity to Predict Functional Recovery in TIMI-3 Reperfused Acute Myocardial Infarction

Presenter: Hiroyuki Hikita

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.